Top Markets
Coin of the day
Wellnex Life Limited Wellnex Life Limited

Wellnex Life Limited

WNX
Kedudukan dalam Saham #34869
Wellnex Life Limited, together with its subsidiaries, develops, markets, and... Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.
Harga Saham
$0.06559149
Disegerakkan terakhir: 2026-08-14
Modal Pasaran
$4.79M
Perubahan (1 hari)
1.09%
Perubahan (1 tahun)
-61.95%
Negara
AU
Perdagangan Wellnex Life Limited (WNX)
Pendapatan untuk Wellnex Life Limited (WNX)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Wellnex Life Limited, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Wellnex Life Limited dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$2.28B -
US
$961.00M -
US
$485.80M -
US
$133.52M -
US
$93.16M -
SG